Global Markets for Contract Pharmaceutical Manufacturing, Research andPackaging: Focus on EuropePublished:September2011Pri...
SUMMARY TABLE GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURINGAND CONTRACT RESEARCH ORGANIZATIONS REVENUE, THROUGH 2016 ($BILL...
CHAPTER SIX: OVERVIEW OF CONTRACT PACKAGINGNEEDING A CONTRACT PACKAGERTABLE 8 REASONS BEHIND NEEDING A CONTRACT PACKAGERTA...
FACILITIES, 2009TABLE 21 (CONTINUED)CHAPTER NINE: INDUSTRY STRUCTURE FOR EUROPEMARKET SHARE OF INDUSTRY LEADERSCONTRACT MA...
CHAPTER TEN: TECHNOLOGY TRANSFERREASONS FOR TECHNOLOGY TRANSFERCHALLENGING PROBLEMS DURING TECHNOLOGY TRANSFERTECHNOLOGY T...
BY FORMULATION, FOR EUROPE, THROUGH 2016 ($ BILLIONS)FIGURE 10 SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE,BY FORMULA...
CONTRACT MANUFACTURE OF SEMISOLID DOSAGE FORMULATIONSMarket OverviewMarket RevenueTABLE 39 SEMISOLID DOSAGE FORM CONTRACT ...
MANUFACTURING, FOR EUROPE, 2009-2016 ($ BILLIONS)Market by FormulationTABLE 47 OTC AND NUTRITIONAL PRODUCTS BY CONTRACTMAN...
THROUGH 2016 ($ MILLIONS)FIGURE 31 CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR EUROPE,2009-2016 ($ BILLIONS)Market Share ...
BY REGION, 2010 (%)MARKET SHARE OF CONTRACT MANUFACTURED OTC AND NUTRITIONALPRODUCTSTABLE 61 OTC AND NUTRITIONAL PRODUCTS ...
TABLE 68 REVENUE FROM CONTRACT MANUFACTURERS OF ANTIVIRALS,IN EUROPE, THROUGH 2016 ($ MILLIONS)FIGURE 46 REVENUE FROM CONT...
SITUATION OF THE EUROPEAN CONTRACTING MARKETCONTRACT MANUFACTURING OF API AND DOSAGE FORMSCONTRACT MANUFACTURING OF OTC AN...
COVIDIENCONTRACT PHARMACEUTICALS LIMITEDCORDEN PHARMA SWITZERLAND LLCDAVOS PHARMADECODE GENETICSDISHMAN PHARMACEUTICALS AN...
REGIS TECHNOLOGIES, INC.SKYEPHARMATALECRIS BIOTHERAPEUTICS INC.VETTER PHARMA INTERNATIONAL GMBHWOCKHARDT LIMITEDWUXI APP T...
Upcoming SlideShare
Loading in …5
×

Global markets for contract pharmaceutical manufacturing, research and packaging focus on europe

454 views

Published on

Published in: Business, Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
454
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Global markets for contract pharmaceutical manufacturing, research and packaging focus on europe

  1. 1. Global Markets for Contract Pharmaceutical Manufacturing, Research andPackaging: Focus on EuropePublished:September2011Price:US $ 4850Report Summary* The global pharmaceutical contract manufacturing and contract researchorganizations revenue reached at $196.5 billion in 2010, it will further growto $217.9 billion in 2011 and is projected to reach at $360.6 billion by 2016,increasing at a compound annual growth rate (CAGR) of 10.6%.* The European contract manufacturing market for OTC and nutritionalproducts was valued at about $46.0 billion in 2010 and is projected to reachapproximately $51.3 in 2011 and it will further grow to $86.5 billion by2016, at a compound annual growth rate (CAGR) of 11%.* The contract research market revenue for Europe in 2009 was $5.8 billion,which reached $6.3 billion in 2010. This market is expected to reach at $6.9billion in 2011 and it will further grow to $10.5 billion by 2016, at acompound annual growth rate (CAGR) of 8.7%.Browse All Pharmaceuticals Market Research ReportsTable Of ContentsCHAPTER ONE: INTRODUCTIONSTUDY OBJECTIVEREASONS FOR DOING THIS STUDYINTENDED AUDIENCESCOPE OF THE STUDYMETHODOLOGYINFORMATION SOURCESABOUT THE AUTHORRELATED BCC RESEARCH REPORTSBCC ONLINE SERVICESDISCLAIMERCHAPTER TWO: SUMMARYSUMMARYSUMMARY (CONTINUED)
  2. 2. SUMMARY TABLE GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURINGAND CONTRACT RESEARCH ORGANIZATIONS REVENUE, THROUGH 2016 ($BILLIONS)SUMMARY FIGURE GLOBAL PHARMACEUTICAL CONTRACTMANUFACTURING AND CONTRACT RESEARCH ORGANIZATIONS REVENUE,2009-2016 ($ BILLIONS)CHAPTER THREE: OVERVIEWDEFINITIONSDEFINITIONS (CONTINUED)HISTORY OF OUTSOURCINGTABLE 1 KEY DEVELOPMENTS IN THE HISTORY OF OUTSOURCINGTABLE 1 (CONTINUED)CHAPTER FOUR: OVERVIEW OF CONTRACT MANUFACTURINGTYPES OF CONTRACT MANUFACTURERSCONTRACT MANUFACTURING TRAITSREQUIREMENTABILITY TO BE FLEXIBLECAPABILITIES WITHOUT COSTADVANTAGES AND DISADVANTAGES OF CONTRACT MANUFACTURINGTABLE 2 KEY ADVANTAGES OF CONTRACT MANUFACTURINGTABLE 3 KEY DISADVANTAGES OF CONTRACT MANUFACTURINGSELECTING A CONTRACT MANUFACTURERTABLE 4 KEY FACTORS IN SELECTING A CONTRACT MANUFACTURERTABLE 4 (CONTINUED)ADDITIONAL FACTS ABOUT CONTRACT MANUFACTURINGLOCATION AND PROXIMITYAFTER-SALES SUPPORTCHAPTER FIVE: OVERVIEW OF CONTRACT RESEARCHOVERVIEW OF CONTRACT RESEARCHSERVICES OFFERED BY CONTRACT RESEARCH ORGANIZATIONSTABLE 5 SERVICES OF CONTRACT RESEARCH ORGANIZATIONSTABLE 5 (CONTINUED)SELECTING A CONTRACT RESEARCH ORGANIZATIONTABLE 6 KEY CHARACTERISITCS IN SELECTING A CONTRACT RESEARCHORGANIZATIONTABLE 6 (CONTINUED)RESEARCH PROVIDED BY CONTRACT RESEARCH ORGNIZATIONSTABLE 7 TYPES OF RESEARCH PROVIDED BY CONTRACT RESEARCHORGANIZATIONSTABLE 7 (CONTINUED)
  3. 3. CHAPTER SIX: OVERVIEW OF CONTRACT PACKAGINGNEEDING A CONTRACT PACKAGERTABLE 8 REASONS BEHIND NEEDING A CONTRACT PACKAGERTABLE 8 (CONTINUED)SELECTING A CONTRACT PACKAGERTABLE 9 KEY CHARACTERISTICS IN SELECTING A CONTRACT PACKAGERHIRING A CONTRACT PACKAGERTABLE 10 KEY STEPS IN HIRING A CONTRACT PACKAGERTYPES OF PACKAGINGTYPES OF PACKAGING (CONTINUED)CHAPTER SEVEN: PROJECT MANAGEMENTSPECIFICATIONS OF PROJECT MANAGEMENTTABLE 11 STEPS OF PROJECT MANAGEMENTTABLE 11 (CONTINUED)PROCESSES OF PROJECT MANAGEMENTTABLE 12 PROCESSES OF PROJECT MANAGEMENTTABLE 12 (CONTINUED)FACTORS INVOLVEDROLE OF THE PROJECT MANAGERTABLE 13 KEY RESPONSIBILITIES OF PROJECT MANAGERSTECHNOLOGY TRANSFERTABLE 14 TECHNOLOGY TRANSFER STEPSCHAPTER EIGHT: REGULATORY ASPECTSREGULATORY ASPECTSTABLE 15 REGULATED FACTORS OF CMO’S AND CRO’STABLE 16 TITLE 21 CFR RULES ASSOCIATED WITH CONTRACTMANUFACTURINGTABLE 16 (CONTINUED)TABLE 16 (CONTINUED)WARNING LETTERSTABLE 17 WARNING LETTERS ISSUED TO CONTRACT MANUFACTURERS,2010TABLE 18 WARNING LETTERS ISSUED TO CONTRACT MANUFACTURERS,2009REGULATORY APPROVALSTABLE 19 REGULATORY APPROVALS OF CONTRACT MANUFACTURERS ANDFACILITIES, JANUARY THROUGH MARCH, 2011TABLE 20 REGULATORY APPROVALS OF CONTRACT MANUFACTURERS ANDFACILITIES, 2010TABLE 20 (CONTINUED)TABLE 21 REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND
  4. 4. FACILITIES, 2009TABLE 21 (CONTINUED)CHAPTER NINE: INDUSTRY STRUCTURE FOR EUROPEMARKET SHARE OF INDUSTRY LEADERSCONTRACT MANUFACTURERS OF BULK DRUGS AND API’STABLE 22 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIESPROVIDING BULK DRUGS/API’S, IN EUROPE, 2010 (%)TABLE 22 (CONTINUED)FIGURE 1 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIESPROVIDING BULK DRUGS/API’S, IN EUROPE, 2010 (%)CONTRACT MANUFACTURERS OF SOLID DOSAGE FORMSTABLE 23 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIESPROVIDING SOLID DOSAGE FORMS, IN EUROPE, 2010 (%)FIGURE 2 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIESPROVIDING SOLID DOSAGE FORMS, IN EUROPE, 2010 (%)CONTRACT MANUFACTURERS OF LIQUID DOSAGE FORMSNONSTERILETABLE 24 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIESPROVIDING NONSTERILE LIQUID DOSAGE FORMS, IN EUROPE, 2010 (%)FIGURE 3 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIESPROVIDING NONSTERILE LIQUID DOSAGE FORMS, IN EUROPE, 2010 (%)STERILETABLE 25 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIESPROVIDING STERILE LIQUID DOSAGE FORMS, IN EUROPE, 2010 (%)FIGURE 4 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIESPROVIDING STERILE LIQUID DOSAGE FORMS, IN EUROPE, 2010 (%)CONTRACT MANUFACTURING OF SEMISOLID DOSAGE FORMSTABLE 26 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIESPROVIDING SEMISOLID DOSAGE FORMS, IN EUROPE, 2010 (%)FIGURE 5 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIESPROVIDING SEMISOLID DOSAGE FORMS, IN EUROPE, 2010 (%)CONTRACT RESEARCH COMPANIESTABLE 27 MARKET SHARE OF CONTRACT RESEARCH COMPANIES, INEUROPE, 2010 (%)FIGURE 6 MARKET SHARE OF CONTRACT RESEARCH COMPANIES, INEUROPE, 2010 (%)TABLE 28 MARKET SHARE OF CONTRACT PACKAGING COMPANIES, INEUROPE, 2010 (%)FIGURE 7 MARKET SHARE OF CONTRACT PACKAGING COMPANIES, INEUROPE, 2010 (%)
  5. 5. CHAPTER TEN: TECHNOLOGY TRANSFERREASONS FOR TECHNOLOGY TRANSFERCHALLENGING PROBLEMS DURING TECHNOLOGY TRANSFERTECHNOLOGY TRANSFERSTEPS FOR SUCCESSFUL TECHNOLOGY TRANSFERTYPES OF CONTRACTUAL AGREEMENTS USED IN TECHNOLOGY TRANSFERCONFIDENTIAL DISCLOSURE AGREEMENT (CDA)MATERIAL TRANSFER AGREEMENT (MTA)ASSIGNMENT DEEDLICENSE AGREEMENTCO-DEVELOPMENT AND CO-MARKETING AGREEMENTSCHARACTERISTICS OF A SUCCESSFUL PROJECTCHARACTERISTICS OF A SUCCESSFUL … (CONTINUED)CHAPTER ELEVEN: NEW DEVELOPMENTSLONZAABBOTTHOSPIRACOVIDIENOTHEROTHER (CONTINUED)CHAPTER TWELVE: MARKET ANALYSIS FOR EUROPECONTRACT MANUFACTURINGCONTRACT MANUFACTURE OF BULK DRUGS/API’SMarket OverviewMarket RevenueTABLE 29 BULK DRUG/API CONTRACT MANUFACTURING REVENUE, FOREUROPE, THROUGH 2016 ($ BILLIONS)FIGURE 8 BULK DRUG/API CONTRACT MANUFACTURING REVENUE, FOREUROPE, 2009-2016 ($ BILLIONS)CONTRACT MANUFACTURE OF ORAL DOSAGE FORMULATIONSSolid Dosage FormulationsMarket OverviewMarket RevenueTABLE 30 SOLID DOSAGE FORM CONTRACT MANUFACTURING, FOREUROPE, THROUGH 2016 ($ BILLIONS)FIGURE 9 SOLID DOSAGE FORM CONTRACT MANUFACTURING, FOREUROPE, 2009- 2016 ($ BILLIONS)Market by FormulationMarket RevenueTABLE 31 SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE,
  6. 6. BY FORMULATION, FOR EUROPE, THROUGH 2016 ($ BILLIONS)FIGURE 10 SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE,BY FORMULATIONS, FOR EUROPE, 2009-2016 ($ BILLIONS)TABLE 32 SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKETSHARES, BY FORMULATION, FOR EUROPE, 2010 (%)FIGURE 11 SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKETSHARES, BY FORMULATIONS, FOR EUROPE, 2010 (%)Liquid Dosage FormulationMarket OverviewMarket RevenueNonsterile FormulationsTABLE 33 LIQUID DOSAGE FORM (NONSTERILE) CONTRACTMANUFACTURING, FOR EUROPE, THROUGH 2016 ($ MILLIONS)FIGURE 12 LIQUID DOSAGE FORM (NONSTERILE) CONTRACTMANUFACTURING, FOR EUROPE, 2009-2016 ($ MILLIONS)Sterile FormulationsTABLE 34 LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING,FOR EUROPE, THROUGH 2016 ($ MILLIONS)FIGURE 13 LIQUID DOSAGE FORM (STERILE) CONTRACTMANUFACTURING, FOR EUROPE, 2009-2016 ($ MILLIONS)Market by FormulationNonsterile FormulationsTABLE 35 LIQUID DOSAGE FORM (NONSTERILE) CONTRACTMANUFACTURING REVENUE, BY FORMULATION, FOR EUROPE, THROUGH2016 ($ MILLIONS)FIGURE 14 LIQUID DOSAGE FORM (NONSTERILE) CONTRACTMANUFACTURING REVENUE, BY FORMULATIONS, FOR EUROPE, 2009-2016($ MILLIONS)TABLE 36 LIQUID DOSAGE FORM (NONSTERILE) CONTRACTMANUFACTURING MARKET SHARES, BY FORMULATION, FOR EUROPE, 2010(%)FIGURE 15 LIQUID DOSAGE FORM (NONSTERILE) CONTRACTMANUFACTURING MARKET SHARES, BY FORMULATIONS, FOR EUROPE,2010 (%)Sterile FormulationsTABLE 37 LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURINGREVENUE, BY FORMULATION, FOR EUROPE, THROUGH 2016 ($ MILLIONS)FIGURE 16 LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURINGREVENUE, BY FORMULATION, FOR EUROPE, 2009-2016 ($ MILLIONS)TABLE 38 LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURINGMARKET SHARE, BY FORMULATION, FOR EUROPE, 2010 (%)FIGURE 17 LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURINGMARKET SHARE, BY FORMULATIONS, FOR EUROPE, 2010 (%)
  7. 7. CONTRACT MANUFACTURE OF SEMISOLID DOSAGE FORMULATIONSMarket OverviewMarket RevenueTABLE 39 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING, FOREUROPE, THROUGH 2016 ($ MILLIONS)FIGURE 18 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING, FOREUROPE, 2009-2016 ($ MILLIONS)TABLE 40 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURINGREVENUE, BY FORMULATION, FOR EUROPE, THROUGH 2016 ($ MILLIONS)FIGURE 19 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURINGREVENUE, BY FORMULATIONS, FOR EUROPE, 2009-2016 ($ MILLIONS)TABLE 41 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURINGMARKET SHARE, BY FORMULATION, FOR EUROPE, 2010 (%)FIGURE 20 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURINGMARKET SHARE, BY FORMULATIONS, FOR EUROPE, 2010 (%)CONTRACT MANUFACTURE OF ADVANCED DRUG DELIVERY PRODUCTSMarket OverviewTABLE 42 CONTRACTING COMPANIES PROVIDING DRUG DELIVERYSYSTEMSMarket RevenueTABLE 43 ADVANCED DRUG DELIVERY SYSTEMS REVENUE, BY CONTRACTMANUFACTURING, FOR EUROPE, THROUGH 2016 ($ BILLIONS)FIGURE 21 ADVANCED DRUG DELIVERY SYSTEMS REVENUE, BY CONTRACTMANUFACTURING, FOR EUROPE, 2009-2016 ($ BILLIONS)Market by FormulationTABLE 44 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACTMANUFACTURING REVENUE, BY FORMULATION, FOR EUROPE, THROUGH2016 ($ MILLIONS)FIGURE 22 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACTMANUFACTURING REVENUE, BY FORMULATIONS, FOR EUROPE, 2009-2016($ MILLIONS)Market ShareTABLE 45 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACTMANUFACTURING MARKET SHARE, BY FORMULATION, FOR EUROPE, 2010(%)FIGURE 23 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACTMANUFACTURING MARKET SHARE, BY FORMULATIONS, FOR EUROPE, 2010(%)CONTRACT MANUFACTURE OF OTC AND NUTRITIONAL PRODUCTSMarket RevenueTABLE 46 OTC AND NUTRITIONAL PRODUCTS REVENUE, BY CONTRACTMANUFACTURING, FOR EUROPE, THROUGH 2016 ($ BILLIONS)FIGURE 24 OTC AND NUTRITIONAL PRODUCTS REVENUE, BY CONTRACT
  8. 8. MANUFACTURING, FOR EUROPE, 2009-2016 ($ BILLIONS)Market by FormulationTABLE 47 OTC AND NUTRITIONAL PRODUCTS BY CONTRACTMANUFACTURING REVENUE, BY FORMULATION, FOR EUROPE, THROUGH2016 ($ BILLIONS)FIGURE 25 OTC AND NUTRITIONAL PRODUCTS BY CONTRACTMANUFACTURING REVENUE, BY FORMULATIONS, FOR EUROPE, 2009-2016($ BILLIONS)Market SharesTABLE 48 OTC AND NUTRITIONAL PRODUCTS BY CONTRACTMANUFACTURING MARKET SHARE, BY FORMULATION, FOR EUROPE, 2010(%)FIGURE 26 OTC AND NUTRITIONAL PRODUCTS BY CONTRACTMANUFACTURING MARKET SHARE, BY FORMULATIONS, FOR EUROPE, 2010(%)CONTRACT RESEARCHMARKET OVERVIEWPartnershipsExpansions of FacilitiesMarket RevenueTABLE 49 CONTRACT RESEARCH REVENUE, FOR EUROPE, THROUGH 2016($ BILLIONS)FIGURE 27 CONTRACT RESEARCH REVENUE, FOR EUROPE, 2009-2016 ($BILLIONS)Market by DisciplineTABLE 50 CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR EUROPE,THROUGH 2016 ($ MILLIONS)FIGURE 28 CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR EUROPE,2009-2016 ($ MILLIONS)Market Share by DisciplineTABLE 51 CONTRACT RESEARCH MARKET SHARE, BY DISCIPLINE, FOREUROPE, 2010 (%)FIGURE 29 CONTRACT RESEARCH MARKET SHARE, BY DISCIPLINE, FOREUROPE, 2010 (%)CONTRACT PACKAGINGMARKET OVERVIEWMarket RevenueTABLE 52 CONTRACT PACKAGING REVENUE, FOR EUROPE, THROUGH 2016($ BILLIONS)FIGURE 30 CONTRACT PACKAGING REVENUE, FOR EUROPE, 2009-2016 ($BILLIONS)Market by Package TypeTABLE 53 CONTRACT PACKAGING REVENUE BY TYPE, FOR EUROPE,
  9. 9. THROUGH 2016 ($ MILLIONS)FIGURE 31 CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR EUROPE,2009-2016 ($ BILLIONS)Market Share by TypeTABLE 54 CONTRACT PACKAGING MARKET SHARE BY TYPE, FOR EUROPE,2010 (%)FIGURE 32 CONTRACT PACKAGING MARKET SHARE BY TYPE, FOR EUROPE,2010 (%)CHAPTER THIRTEEN: MARKET SHARE BY REGIONMARKET SHARE OF CONTRACT MANUFACTURED API’STABLE 55 BULK DRUG/API CONTRACT MANUFACTURING MARKET SHARE,BY REGION, 2010 (%)FIGURE 33 BULK DRUG/API CONTRACT MANUFACTURING MARKET SHARE,BY REGION, 2010 (%)MARKET SHARE OF CONTRACT MANUFACTURED SOLID DOSAGE FORMSTABLE 56 SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKETSHARE, BY REGION, 2010 (%)FIGURE 34 SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKETSHARE, BY REGION, 2010 (%)MARKET SHARE OF CONTRACT MANUFACTURED LIQUID DOSAGEFORMULATIONSNONSTERILE FORMULATIONSTABLE 57 LIQUID DOSAGE FORM (NONSTERILE) CONTRACTMANUFACTURING MARKET SHARE, BY REGION, 2010 (%)FIGURE 35 LIQUID DOSAGE FORM (NONSTERILE) CONTRACTMANUFACTURING MARKET SHARE, BY REGION, 2010 (%)STERILE FORMULATIONSTABLE 58 LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURINGMARKET SHARE, BY REGION, 2010 (%)FIGURE 36 LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURINGMARKET SHARE, BY REGION, 2010 (%)MARKET SHARE OF CONTRACT MANUFACTURED SEMISOLID DOSAGEFORMULATIONSTABLE 59 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURINGMARKET SHARES, BY REGION, 2010 (%)FIGURE 37 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURINGMARKET SHARE, BY REGION, 2010 (%)MARKET SHARE OF CONTRACT MANUFACTURED ADVANCED DRUGDELIVERY PRODUCTSTABLE 60 DRUG DELIVERY CONTRACT MANUFACTURING MARKET SHARE,BY REGION, 2010 (%)FIGURE 38 DRUG DELIVERY CONTRACT MANUFACTURING MARKET SHARE,
  10. 10. BY REGION, 2010 (%)MARKET SHARE OF CONTRACT MANUFACTURED OTC AND NUTRITIONALPRODUCTSTABLE 61 OTC AND NUTRITIONAL PRODUCTS CONTRACT MANUFACTURINGMARKET SHARE, BY REGION, 2010 (%)FIGURE 39 OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURINGMARKET SHARE, BY REGION, 2010 (%)MARKET SHARE OF CONTRACT RESEARCHTABLE 62 CONTRACT RESEARCH MARKET SHARE, BY REGION, 2010 (%)FIGURE 40 CONTRACT RESEARCH MARKET SHARE, BY REGION, 2010 (%)MARKET SHARE OF CONTRACT PACKAGINGTABLE 63 CONTRACT PACKAGING MARKET SHARE, BY REGION, 2010 (%)FIGURE 41 CONTRACT PACKAGING MARKET SHARE, BY REGION, 2010(%)CHAPTER FOURTEEN: CONTRACT MANUFACTURING APPLICATIONSFOR EUROPEAN MARKETSCARDIOVASCULAR DRUGSMARKET REVENUETABLE 64 REVENUE FROM CONTRACT MANUFACTURERS OFCARDIOVASCULAR DRUGS, IN EUROPE, THROUGH 2016 ($ MILLIONS)FIGURE 42 REVENUE FROM CONTRACT MANUFACTURERS OFCARDIOVASCULAR DRUGS, IN EUROPE, 2009-2016 ($ MILLIONS)REPRODUCTIVE DRUG MARKETMARKET REVENUETABLE 65 REVENUE FROM CONTRACT MANUFACTURERS OFREPRODUCTIVE DRUGS, IN EUROPE, THROUGH 2016 ($ MILLIONS)FIGURE 43 REVENUE FROM CONTRACT MANUFACTURERS OFREPRODUCTIVE DRUGS, IN EUROPE, 2009-2016 ($ MILLIONS)ONCOLOGY DRUG MARKETMARKET REVENUETABLE 66 REVENUE FROM CONTRACT MANUFACTURERS OF ONCOLOGYDRUGS, IN EUROPE, THROUGH 2016 ($ MILLIONS)FIGURE 44 REVENUE FROM CONTRACT MANUFACTURERS OF ONCOLOGYDRUGS, IN EUROPE, 2009-2016 ($ MILLIONS)ANALGESICS MARKETMARKET REVENUETABLE 67 REVENUE FROM CONTRACT MANUFACTURERS OF ANALGESICS,IN EUROPE, THROUGH 2016 ($ MILLIONS)FIGURE 45 REVENUE FROM CONTRACT MANUFACTURERS OF ANALGESICS,IN EUROPE, 2009-2016 ($ MILLIONS)ANTIVIRAL DRUG MARKETMARKET REVENUE
  11. 11. TABLE 68 REVENUE FROM CONTRACT MANUFACTURERS OF ANTIVIRALS,IN EUROPE, THROUGH 2016 ($ MILLIONS)FIGURE 46 REVENUE FROM CONTRACT MANUFACTURERS OF ANTIVIRALS,IN EUROPE, 2009-2016 ($ MILLIONS)ANTIBIOTICS MARKETMARKET REVENUETABLE 69 REVENUE FROM CONTRACT MANUFACTURERS OF ANTIBIOTICS,IN EUROPE, THROUGH 2016 ($ MILLIONS)FIGURE 47 REVENUE FROM CONTRACT MANUFACTURERS OF ANTIBIOTICS,IN EUROPE, 2009-2016 ($ MILLIONS)MARKETS FOR OTHER DRUGSMARKET REVENUETABLE 70 REVENUE FROM CONTRACT MANUFACTURERS OF OTHER DRUGS,IN EUROPE, THROUGH 2016 ($ BILLIONS)FIGURE 48 REVENUE FROM CONTRACT MANUFACTURERS OF OTHERDRUGS, IN EUROPE, 2009-2016 ($ BILLIONS)CHAPTER FIFTEEN: PATENT ANALYSISPATENTS BY YEARTABLE 71 NUMBER OF SIGNIFICANT PATENTS, BY YEAR, 2009-2011FIGURE 49 NUMBER OF PATENTS, BY YEAR, 2009-MAY 31, 2011FIGURE 50 NUMBER OF PATENTS, BY YEAR, 2009-MAY 31, 2011 (%)PATENTS BY COMPANYTABLE 72 NUMBER OF U.S. PATENTS, BY COMPANY, 2009-2011FIGURE 51 NUMBER OF U.S. PATENTS, BY COMPANY, 2009-2011PATENTS BY COUNTRYTABLE 73 NUMBER OF U.S. PATENTS, BY COUNTRY, 1/1/2009 TO5/31/2011FIGURE 52 NUMBER OF U.S. PATENTS, BY COUNTRY, 1/1/2009 TO5/31/2011TABLE 74 PATENT SHARES, BY COUNTRY, 1/1/2009 TO 5/31/2011 (%)FIGURE 53 PATENT SHARES, BY COUNTRY, 1/1/2009 TO 5/31/2011 (%)PATENTS BY EMPHASISTABLE 75 PATENTS, BY EMPHASIS, 1/1/2009 TO 5/31/2011FIGURE 54 NUMBER OF U.S. PATENTS, BY EMPHASIS, 1/1/2009 TO5/31/2011CHAPTER SIXTEEN: CURRENT ENVIRONMENTSITUATION OF THE NORTH AMERICAN CONTRACTING MARKETSCONTRACT MANUFACTURING OF API AND DOSAGE FORMSCONTRACT MANUFACTURING OF OTC AND NUTRACEUTICALSCONTRACT RESEARCHCONTRACT PACKAGING
  12. 12. SITUATION OF THE EUROPEAN CONTRACTING MARKETCONTRACT MANUFACTURING OF API AND DOSAGE FORMSCONTRACT MANUFACTURING OF OTC AND NUTRACEUTICALSCONTRACT RESEARCHCONTRACT PACKAGINGSITUATION OF THE ROW CONTRACTING MARKETCONTRACT MANUFACTURING OF API AND DOSAGE FORMSCONTRACT MANUFACTURING OF OTC AND NUTRACEUTICALSCONTRACT RESEARCHCONTRACT PACKAGINGOPPORTUNITIES AND CHALLENGES OF THE CURRENT CONTRACTMANUFACTURING INDUSTRYOPPORTUNITIES AND CHALLENGES…(CONTINUED)OPPORTUNITIES AND CHALLENGES…(CONTINUED)CHAPTER SEVENTEEN: COMPANY PROFILESAAI PHARMA, INC.ABBOTT LABORATORIESAEROGEN LTD.ALKERMESALTHEA TECHNOLOGIESAMCORAMERISOURCE BERGEN CORPORATIONAMPAC FINE CHEMICALSALBANY MOLECULAR RESEARCH INC. (AMRI)AP PHARMA INC.APTUIT INC.ARADIGM CORPORATIONBASF SEBAXTER HEALTHCAREBCM/BOOTS MANUFACTURINGBOEHRINGER INGELHEIMBRISTOL-MYERS SQUIBBCAMBREX CORPORATIONCANGENE CORPORATIONCATALENT PHARMA SOLUTIONSCEDARBURG HAUSER PHARMACEUTICALS INC.CENEXICHARLES RIVER LABORATORIESCHEMBRIDGE CORP.CLEARSTONE CENTRAL LABORATORIESCONFAB LABORATORIESCOVANCE INC.
  13. 13. COVIDIENCONTRACT PHARMACEUTICALS LIMITEDCORDEN PHARMA SWITZERLAND LLCDAVOS PHARMADECODE GENETICSDISHMAN PHARMACEUTICALS AND CHEMICALS LTD.DOW CHEMICALDPT LABORATORIES INC.DR. REDDY’S LABORATORIESDSM PHARMACEUTICAL PRODUCTSFUJIFILM DIOSYNTH BIOTECHNOLOGYELAN DRUG TECHNOLOGIESEVOTEC AGFULCRUM PHARMA PLCGIRINDUS AGGLAXOSMITHKLINEHOSPIRAHAUPT PHARMA AGHOVIONE S.AICON PLCINC RESEARCH, INC.JUBILANT LIFESCIENCESKENDLE INTERNATIONAL INC.KP PHARMACEUTICAL TECHNOLOGIES INC.K.V. PHARMACEUTICAL CO.LIGAND PHARMACEUTICALS, INC.LONZA GROUPLYNE LABORATORIESMERCK / MSD BIOMANUFACTURING NETWORKMIKART INCNEXTPHARMA TECHNOLOGIESNORWICH PHARMACEUTICALSNOVAVAX, INC.OMNICARE CLINICAL RESEARCHPAREXEL INTERNATIONAL CORPORATIONPATHEON INC.PERRIGO COMPANYPFIZER (KING PHARMACEUTICALSPIRAMAL HEALTHCARE LIMITEDPPDPRA INTERNATIONALQUINTILESRANBAXY
  14. 14. REGIS TECHNOLOGIES, INC.SKYEPHARMATALECRIS BIOTHERAPEUTICS INC.VETTER PHARMA INTERNATIONAL GMBHWOCKHARDT LIMITEDWUXI APP TECXCELLEREX LLCZACH SYSTEM S.P.AAPPENDIX I: ABBREVIATIONSAbout Us:ReportsnReports is an online library of over 100,000+ market researchreports and in-depth market research studies & analysis of over 5000 micromarkets. We provide 24/7 online and offline support to our customers. Getin touch with us for your needs of market research reports.Follow us on Twitter: http://twitter.com/marketsreportsOur Facebook Page:http://www.facebook.com/pages/ReportsnReports/191441427571689Contact:Mr.Priyank7557 Rambler road,Suite727,Dallas,TX75231Tel: + 1 888 391 5441E-mail: sales@reportsandreports.comhttp://www.reportsnreports.comVisit our Market Research Blog

×